Opioid-Free Pain Protocol After Shoulder Arthroplasty
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
This randomized, single blinded, clinical trial aims to investigate the efficacy of a
multimodal pain control regimen for shoulder arthroplasty. Patients who receive a multimodal
pain control regimen alone (study group) will be compared to patients who receive a
multimodal pain control regimen plus a standard prescription of an opioid containing
medication (comparison group). The primary outcome is average daily Numerical Rating Scale
(NRS) pain score in the first 10 days after surgery. We hypothesize that there will be no
significant difference in the primary outcome between the two groups.